Clinical trial

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to…

NCT00373620 · Korean Gynecologic Oncology Group, Other · Unknown status

Key facts

NCT number NCT00373620
Title A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
Official title A Phase II Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy in High-Risk Endometrial Cancer Patients After Operation.
Lead sponsor Korean Gynecologic Oncology Group, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Endometrial Cancer
Intervention type Drug
Interventions paclitaxel
Enrollment 50
Start date Jan 1, 2006
First posted Sep 8, 2006
Last update posted Sep 8, 2006
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies